FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2513123391> ?p ?o ?g. }

• W2513123391 endingPage "971" @default.
• W2513123391 startingPage "971" @default.
• W2513123391 abstract "<h3>Importance</h3> Suicidal behavior is a leading cause of injury and death worldwide, and previous cross-sectional studies have demonstrated that nonmedical use of prescription drugs (NMUPD) was associated with suicidality. However, there is not any study in China having examined the longitudinal relationships between NMUPD, suicidal ideation, and suicidal attempts, as well as explored the potential mediating effects of depressive symptoms. <h3>Objective</h3> To determine whether baseline NMUPD was associated with subsequent suicidal ideation and attempts while controlling for depressive symptoms and to determine whether the increased risks were mediated by depressive symptoms. <h3>Design, Setting, and Participants</h3> In this longitudinal study, a total of 3273 students in randomly selected schools in Guangzhou were surveyed from 2009 to 2010 (response rate, 96.8%) and followed up at 1 year (2011-2012; retention rate, 96.1%). The dates of data analysis were October 9, 2015, to October 15, 2015; additional data analysis occurred March 23, 2016, to March 29, 2016. <h3>Main Outcomes and Measures</h3> Suicidal ideation, suicidal attempts, NMUPD, depressive symptoms, and alcohol-related problems. <h3>Results</h3> Overall, 3273 adolescents (mean [SD] age, 13.7 [1.0] years) were recruited for this study. The final results showed that after controlling for sociodemographic information (including sex, age, household socioeconomic status, and living arrangements), baseline depressive symptoms, baseline alcohol-related problems, baseline suicidal ideation, and baseline suicidal attempts, baseline opioids misuse (adjusted odds ratio [AOR], 2.31; 95% CI, 1.30-4.11), sedatives misuse (AOR, 4.46; 95% CI, 1.54-7.94), and nonmedical use of any prescription drug (AOR, 1.97; 95% CI, 1.21-3.23) were positively associated with suicidal ideation at follow-up. Additionally, baseline opioid misuse (AOR, 3.39; 95% CI, 1.33-5.63) and nonmedical use of any prescription drug (AOR, 2.91; 95% CI, 1.26-3.71) were also associated with subsequent suicidal attempts after controlling for sex, age, household socioeconomic status, living arrangements, depressive symptoms, alcohol-related problems, suicidal ideation, and suicidal attempts at baseline. There were significant standardized indirect effects of baseline opioids misuse on subsequent suicidal ideation (standardized β estimate = 0.020; 95% CI, 0.010-0.030) and suicidal attempts (standardized β estimate = 0.009; 95% CI, 0.004-0.015) through depressive symptoms; the standardized indirect effect of baseline sedatives misuse on subsequent suicidal ideation through depressive symptoms was also significant (standardized β estimate = 0.016; 95% CI, 0.005-0.026). <h3>Conclusions and Relevance</h3> In this study, NMUPD at baseline was associated with subsequent suicidal ideation and attempts. These findings support that proper surveillance systems with the potential to reduce adolescent suicidality should be established to control and supervise suicidality and NMUPD among Chinese adolescents." @default.
• W2513123391 created "2016-09-16" @default.
• W2513123391 creator A5016208356 @default.
• W2513123391 creator A5029158275 @default.
• W2513123391 creator A5032438398 @default.
• W2513123391 creator A5037176916 @default.
• W2513123391 creator A5044304844 @default.
• W2513123391 creator A5046344781 @default.
• W2513123391 creator A5048181107 @default.
• W2513123391 creator A5052437697 @default.
• W2513123391 creator A5075716897 @default.
• W2513123391 creator A5083537892 @default.
• W2513123391 date "2016-10-01" @default.
• W2513123391 modified "2023-10-12" @default.
• W2513123391 title "Association Between Nonmedical Use of Prescription Drugs and Suicidal Behavior Among Adolescents" @default.
• W2513123391 cites W1896183155 @default.
• W2513123391 cites W1934392415 @default.
• W2513123391 cites W1965798993 @default.
• W2513123391 cites W1968240467 @default.
• W2513123391 cites W1983353697 @default.
• W2513123391 cites W1984429945 @default.
• W2513123391 cites W1994495351 @default.
• W2513123391 cites W1995640529 @default.
• W2513123391 cites W1996236157 @default.
• W2513123391 cites W2001164393 @default.
• W2513123391 cites W2012322439 @default.
• W2513123391 cites W2017960527 @default.
• W2513123391 cites W2021515412 @default.
• W2513123391 cites W2022003649 @default.
• W2513123391 cites W2029507855 @default.
• W2513123391 cites W2038702827 @default.
• W2513123391 cites W2042381512 @default.
• W2513123391 cites W2050021971 @default.
• W2513123391 cites W2050111314 @default.
• W2513123391 cites W2052963703 @default.
• W2513123391 cites W2070123636 @default.
• W2513123391 cites W2072657366 @default.
• W2513123391 cites W2073935929 @default.
• W2513123391 cites W2078129874 @default.
• W2513123391 cites W2092404545 @default.
• W2513123391 cites W2094631599 @default.
• W2513123391 cites W2095321699 @default.
• W2513123391 cites W2099588241 @default.
• W2513123391 cites W2111627183 @default.
• W2513123391 cites W2113168655 @default.
• W2513123391 cites W2123612404 @default.
• W2513123391 cites W2135937358 @default.
• W2513123391 cites W2145101656 @default.
• W2513123391 cites W2153549946 @default.
• W2513123391 cites W2159061031 @default.
• W2513123391 cites W2262654267 @default.
• W2513123391 cites W2268716675 @default.
• W2513123391 cites W2272661266 @default.
• W2513123391 cites W2328505438 @default.
• W2513123391 cites W913669722 @default.
• W2513123391 doi "https://doi.org/10.1001/jamapediatrics.2016.1802" @default.
• W2513123391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27533915" @default.
• W2513123391 hasPublicationYear "2016" @default.
• W2513123391 type Work @default.
• W2513123391 sameAs 2513123391 @default.
• W2513123391 citedByCount "63" @default.
• W2513123391 countsByYear W25131233912017 @default.
• W2513123391 countsByYear W25131233912018 @default.
• W2513123391 countsByYear W25131233912019 @default.
• W2513123391 countsByYear W25131233912020 @default.
• W2513123391 countsByYear W25131233912021 @default.
• W2513123391 countsByYear W25131233912022 @default.
• W2513123391 countsByYear W25131233912023 @default.
• W2513123391 crossrefType "journal-article" @default.
• W2513123391 hasAuthorship W2513123391A5016208356 @default.
• W2513123391 hasAuthorship W2513123391A5029158275 @default.
• W2513123391 hasAuthorship W2513123391A5032438398 @default.
• W2513123391 hasAuthorship W2513123391A5037176916 @default.
• W2513123391 hasAuthorship W2513123391A5044304844 @default.
• W2513123391 hasAuthorship W2513123391A5046344781 @default.
• W2513123391 hasAuthorship W2513123391A5048181107 @default.
• W2513123391 hasAuthorship W2513123391A5052437697 @default.
• W2513123391 hasAuthorship W2513123391A5075716897 @default.
• W2513123391 hasAuthorship W2513123391A5083537892 @default.
• W2513123391 hasConcept C118552586 @default.
• W2513123391 hasConcept C142724271 @default.
• W2513123391 hasConcept C144024400 @default.
• W2513123391 hasConcept C147077947 @default.
• W2513123391 hasConcept C149923435 @default.
• W2513123391 hasConcept C187155963 @default.
• W2513123391 hasConcept C190385971 @default.
• W2513123391 hasConcept C2426938 @default.
• W2513123391 hasConcept C2776641880 @default.
• W2513123391 hasConcept C2908647359 @default.
• W2513123391 hasConcept C3017944768 @default.
• W2513123391 hasConcept C526869908 @default.
• W2513123391 hasConcept C71924100 @default.
• W2513123391 hasConcept C98274493 @default.
• W2513123391 hasConcept C99454951 @default.
• W2513123391 hasConceptScore W2513123391C118552586 @default.
• W2513123391 hasConceptScore W2513123391C142724271 @default.
• W2513123391 hasConceptScore W2513123391C144024400 @default.
• W2513123391 hasConceptScore W2513123391C147077947 @default.

• next